Upstream Bio (UPB) Leases (2023 - 2025)

Upstream Bio has reported Leases over the past 3 years, most recently at $1.2 million for Q4 2025.

  • Quarterly results put Leases at $1.2 million for Q4 2025, down 31.46% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (down 31.46% YoY), and the annual figure for FY2025 was $1.2 million, down 31.46%.
  • Leases for Q4 2025 was $1.2 million at Upstream Bio, down from $1.4 million in the prior quarter.
  • Over the last five years, Leases for UPB hit a ceiling of $1.9 million in Q3 2024 and a floor of $43000.0 in Q4 2023.
  • Median Leases over the past 3 years was $1.5 million (2025), compared with a mean of $1.4 million.
  • Biggest five-year swings in Leases: soared 4046.51% in 2024 and later plummeted 31.46% in 2025.
  • Upstream Bio's Leases stood at $43000.0 in 2023, then soared by 4046.51% to $1.8 million in 2024, then plummeted by 31.46% to $1.2 million in 2025.
  • The last three reported values for Leases were $1.2 million (Q4 2025), $1.4 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.